4833M 15/850 (Actoplus met 850 mg / 15 mg)
Generic Name: metformin/pioglitazone
Pill imprint 4833M 15/850 has been identified as Actoplus met 850 mg / 15 mg.
ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 4833M 15/850
- Generic Name:
- 850 mg / 15 mg
- 18.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
hypromellose 2910 (6 mPa.s)
polyethylene glycol 8000
|NDC Code||Manufacturer / Repackager|
|54868-5553||Physicians Total Care Inc (repackager)|
|35356-0130||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about ActoPlus Met (metformin / pioglitazone)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.